 Effect enalapril survival patients reduced ventricular ejection fractions congestive heart failure SOLVD Investigators BACKGROUND Patients congestive heart failure high mortality rate effect angiotensin-converting-enzyme inhibitor enalapril mortality hospitalization patients chronic heart failure ejection fractions equal METHODS Patients conventional treatment heart failure placebo doses mg day double-bind trial percent patients New York Heart Association functional classes II III follow-up months RESULTS deaths placebo group percent enalapril group percent reduction risk percent percent confidence interval percent reductions mortality several categories cardiac deaths reduction deaths heart failure placebo group enalapril group reduction risk percent percent confidence interval percent little apparent effect treatment deaths due pump failure patients heart failure placebo group enalapril group risk reduction percent percent confidence interval percent CONCLUSIONS addition enalapril conventional therapy mortality hospitalizations heart failure patients chronic congestive heart failure reduced ejection fractions